Serina Therapeutics Inc (SER)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $36.93M
Last updated: Nov 17, 2026 at 11:04 AM ET
Serina Therapeutics Inc (SER) Earnings: Report Dates and Results
Serina Therapeutics (SER) is expected to report earnings on May 10, 2027. In the quarter ended Sep 30, 2026, Serina Therapeutics reported EPS of -$0.31, above the -$0.34 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
SER has an expected report date of May 10, 2027.
Earnings History
Of the 8 quarters below that had an estimate, SER beat 4 and missed 4. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 184.79% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.31 | -$0.34 | -$0.37 - -$0.31 | +8.82% | Beat | N/A | 2 | 2 up, 0 down | Nov 12, 2026 | $125000 |
| Jun 30, 2026 | -$0.55 | -$0.35 | -$0.35 - -$0.35 | -57.14% | Miss | N/A | 1 | 1 up, 0 down | Aug 13, 2026 | N/A |
| Mar 31, 2026 | -$0.53 | -$0.44 | -$0.44 - -$0.44 | -20.45% | Miss | N/A | 1 | 1 up, 0 down | May 14, 2026 | N/A |
| Dec 31, 2025 | -$0.31 | -$0.50 | -$0.50 - -$0.50 | +38.00% | Beat | N/A | 1 | 0 up, 1 down | Mar 25, 2026 | N/A |
| Sep 30, 2025 | -$0.51 | -$0.53 | -$0.59 - -$0.47 | +3.77% | Beat | -488.7% | 2 | 0 up, 1 down | Nov 13, 2025 | N/A |
| Jun 30, 2025 | -$0.66 | -$0.42 | -$0.43 - -$0.36 | -57.14% | Miss | -228.8% | 2 | 1 up, 0 down | Aug 11, 2025 | $130000 |
| Mar 31, 2025 | -$0.49 | -$0.62 | -$0.62 - -$0.62 | +20.97% | Beat | N/A | 1 | 0 up, 0 down | May 8, 2025 | N/A |
| Dec 31, 2024 | -$0.36 | $0.42 | $0.42 - $0.42 | -184.79% | Miss | N/A | 1 | 0 up, 0 down | Mar 24, 2025 | N/A |
| Sep 30, 2024 | $0.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2024 | $14000 |
| Jun 30, 2024 | $0.51 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 9, 2024 | $51000 |
| Mar 31, 2024 | -$3.38 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 14, 2024 | $5000 |
| Dec 31, 2023 | -$3.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 22, 2024 | $3.09M |
| Sep 30, 2023 | -$5.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2023 | $29000 |
| Jun 30, 2023 | -$2.47 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 28, 2023 | $7000 |
| Mar 31, 2023 | -$3.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2023 | $30000 |
| Dec 31, 2022 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2023 | $8000 |
| Sep 30, 2022 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 29, 2022 | $9000 |
| Jun 30, 2022 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 28, 2022 | $12000 |
| Mar 31, 2022 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 28, 2022 | $5000 |
| Dec 31, 2021 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2022 | $27000 |
| Sep 30, 2021 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 29, 2021 | $24000 |
| Jun 30, 2021 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 28, 2021 | $37000 |
| Mar 31, 2021 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 28, 2021 | $56000 |
| Dec 31, 2020 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2021 | $292000 |
| Sep 30, 2020 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 16, 2020 | $69000 |
| Jun 30, 2020 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2020 | N/A |
| Mar 31, 2020 | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2020 | N/A |
| Dec 31, 2019 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 | $549000 |
| Sep 30, 2019 | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2019 | $411000 |
| Jun 30, 2019 | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2019 | $380000 |
| Mar 31, 2019 | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2019 | $388000 |
| Dec 31, 2018 | -$3.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2019 | $313000 |
| Sep 30, 2018 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 22, 2018 | $380000 |
| Jun 30, 2018 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 19, 2018 | $464000 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.97, after -$3.09 the year before. It was -$3.19 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.97 | N/A |
| Dec 31, 2024 | -$3.09 | N/A |
| Dec 31, 2023 | -$13.72 | N/A |
| Dec 31, 2022 | -$0.27 | N/A |
| Dec 31, 2021 | -$0.23 | N/A |
| Dec 31, 2020 | -$0.28 | N/A |
| Dec 31, 2019 | -$0.33 | N/A |
| Dec 31, 2018 | -$3.19 | N/A |
Frequently Asked Questions About SER
When is Serina Therapeutics's next earnings date?
Serina Therapeutics's next earnings report is expected for May 10, 2027.
Did SER beat earnings estimates last quarter?
Yes. Serina Therapeutics reported EPS of -$0.31 for the quarter ended Sep 30, 2026, above the -$0.34 estimate, a 8.82% surprise.
What EPS do analysts expect from SER next quarter?
The consensus EPS estimate for Serina Therapeutics for the quarter ending Dec 31, 2026 is -$0.30 from 3 analysts, with estimates from -$0.32 to -$0.28.
How often does SER beat earnings estimates?
Serina Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -31.00%.
SER pages: Overview, Earnings, Forecast, Financials, Competitors